SCHEMBL715425

SCHEMBL715425

CCCCN(C(C)=O)C(C)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA9 Q16790 2/20 0.36
CA2 P00918 1/20 0.36
MAPK1 P28482 1/20 0.36
ACE2 Q9BYF1 1/20 0.36
EPHX2 P34913 1/20 0.36
GPR84 Q9NQS5 3/20 0.35
FFAR1 O14842 1/20 0.35
KDM5A P29375 2/20 0.35
KDM4C Q9H3R0 2/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP8 P22894 1/20 0.34
LCK P06239 1/20 0.34
PPARD Q03181 1/20 0.34
ZDHHC20 Q5W0Z9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30859297 1.00 CA12 (0.36) CA12CA1CA9CA2MAPK1
SCHEMBL28897083 0.94 EPHX2 (0.41) CA2MAPK1ACE2EPHX2GPR84
SCHEMBL9151091 0.92 EPHX2 (0.43) ACE2EPHX2GPR84FFAR1KDM5A
SCHEMBL9151095 0.92 EPHX2 (0.43) ACE2EPHX2GPR84FFAR1KDM5A
SCHEMBL15126410 0.88 TDP1 (0.34) CA12CA9CA2MAPK1ACE2
SCHEMBL498398 0.81 EPHX2 (0.41) CA12CA1CA9EPHX2KDM5A
SCHEMBL9150918 0.79 EPHX2 (0.46) EPHX2GPR84FFAR1KDM5AKDM4C
SCHEMBL9150924 0.79 EPHX2 (0.46) EPHX2GPR84FFAR1KDM5AKDM4C
SCHEMBL23052899 0.79 CA1 (0.42) CA12CA1CA9CA2MAPK1
SCHEMBL2995967 0.79 ALDH1A1 (0.35) CA12CA1CA9EPHX2KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120076781-A Shaving aid composition and shaving kit 吉列有限责任公司 2025-05-30 CN claimed
CN-120076782-A Method for removing hair from an area of skin 吉列有限责任公司 2025-05-30 CN claimed
EP-4385487-A1 SHAVING AID COMPOSITION AND SHAVING KIT The Gillette Company LLC (US) 2024-06-19 EP claimed
US-20240156693-A1 SHAVING AID COMPOSITION AND SHAVING KIT THE GILLETTE COMPANY LLC 2024-05-16 US claimed
WO-2024091892-A1 SHAVING AID COMPOSITION AND SHAVING KIT THE GILLETTE COMPANY LLC (US) 2024-05-02 WO claimed
WO-2024091891-A1 METHOD FOR REMOVING HAIR FROM AN AREA OF SKIN THE GILLETTE COMPANY LLC (US) 2024-05-02 WO claimed
EP-4360615-A1 METHOD FOR REMOVING HAIR FROM AN AREA OF SKIN The Gillette Company LLC (US) 2024-05-01 EP claimed
EP-4360613-A1 METHOD FOR REMOVING HAIR FROM AN AREA OF SKIN The Gillette Company LLC (US) 2024-05-01 EP claimed
EP-4360614-A1 SHAVING AID COMPOSITION AND SHAVING KIT The Gillette Company LLC (US) 2024-05-01 EP claimed
EP-3407865-B1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE N-SUBSTITUTED AMIDE OREAL (FR) 2023-10-18 EP claimed
EP-1618869-B1 Process for photostabilising a dibenzoylmethane derivative with an arylalkyl benzoate derivative and an amide oil; sunscreening cosmetic compositions L'ORÉAL (FR) 2016-12-21 EP claimed
US-6872401-B2 Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil L'OREAL (FR) 2005-03-29 US claimed
US-20040009200-A1 Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil SOCIETE L'OREAL S.A. (FR) 2004-01-15 US claimed
EP-3313534-B1 SUPERABSORBENT POLYMERS AND STARCH POWDERS FOR USE IN SKIN CARE COMPOSITIONS PROCTER & GAMBLE (US) 2026-05-20 EP disclosed
US-20260115122-A1 PERSONAL CARE COMPOSITIONS COMPRISING PANCRATIUM MARITIMUM Galderma Holding SA (CH) 2026-04-30 US disclosed
US-12605316-B2 Alkenone-based formulations for topical applications WOODS HOLE OCEANOGRAPHIC INSTITUTION (US) 2026-04-21 US disclosed
US-7364720-B2 Photostabilization of dibenzoylmethane UV-screening agents with arylalkyl benzoate compounds/amide-based oils and photoprotective compositions comprised thereof L'OREAL (FR) 2008-04-29 US disclosed
US-6872401-B2 Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil L'OREAL (FR) 2005-03-29 US disclosed
US-20040009200-A1 Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil SOCIETE L'OREAL S.A. (FR) 2004-01-15 US disclosed
US-6120780-A THICKENING, GELATION L'OREAL (FR) 2000-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605316-B2 Alkenone-based formulations for topical applications CUTA, FLNA, TELO2 CA12 4405/4885CA1 4884/4885CA9 4764/4885
US-20260115122-A1 PERSONAL CARE COMPOSITIONS COMPRISING PANCRATIUM MARITIMUM B3GNT2, GLA, AMPD2 CA12 1607/4885CA1 4785/4885CA9 3277/4885
US-20040009200-A1 Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil KRT18, DHCR24, FABP4 CA12 3894/4885CA1 3726/4885CA9 4149/4885
US-20240156693-A1 SHAVING AID COMPOSITION AND SHAVING KIT CUTA, CTNNA1, CTNND1 CA12 2490/4885CA1 2116/4885CA9 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.